AOXG — Aoxing Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.58m
- $20.20m
- $32.33m
Annual cashflow statement for Aoxing Pharmaceutical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2012 June 30th | 2013 June 30th | 2014 June 30th | 2015 June 30th | 2016 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.8 | -16.8 | -8.22 | 5.49 | 2.06 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 14.1 | 7.67 | 0.601 | 0.374 | 1.26 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.678 | -0.302 | -1.11 | -0.805 | -5.53 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -1.33 | -8.32 | -7.73 | 3.03 | -0.535 |
| Capital Expenditures | -0.752 | -0.439 | -0.269 | -2.71 | -0.118 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.752 | -0.439 | -0.269 | -2.71 | -0.118 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.82 | 8.99 | 6.31 | 2.67 | 2.95 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.912 | 0.325 | -1.68 | 3.04 | 1.54 |